Similar companies
| Company | Revenue | |
|---|---|---|
 |
Nurix TherapeuticsNRIX |
9M 44.6% |
Did Lexaria Bioscience Beat Earnings?
Lexaria Bioscience (LEXX) reported Q2 '26 revenue of $0, down 100.0% year-over-year.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Lexaria Bioscience’s job postings, web traffic, and employee business outlook. See the full LEXX stock analysis or the earnings calendar for upcoming reports.
Lexaria Bioscience Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 84,000 | 180,000 | 170,000 | 170,000 | 170,000 | — | 20,000 | — |
| Gross margin | 100.0% | 98.5% | 100.0% | 100.0% | 100.0% | — | 100.0% | — |
| Operating margin | -2,622.7% | -1,463.0% | -1,581.0% | -2,155.4% | -1,545.2% | — | -7,259.5% | — |
| Net income | -2.2M | -2.7M | -2.7M | -3.8M | -2.7M | -1.6M | -1.4M | -2M |
| Net margin | -2,600.9% | -1,470.0% | -1,559.3% | -2,177.6% | -1,549.3% | — | -7,249.9% | — |
| EPS | — | — | — | — | — | — | — | — |
Lexaria Bioscience Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Lexaria Bioscience’s quarterly revenue moved from $84,000 to $0.
When Is Lexaria Bioscience’s Next Earnings Date?
Lexaria Bioscience reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the LEXX earnings calendar.
Frequently Asked Questions: Lexaria Bioscience Earnings
Lexaria Bioscience's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Lexaria Bioscience reported Q2 '26 revenue of $0, down 100.0% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the LEXX AI Score.
